En-Cun Hou

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The survival following transarterial chemoembolization (TACE) alone is still low in unresectable hepatocellular carcinoma (HCC) with almost patients developing disease progression after treatment. There is need to investigate additional therapeutic options that would intensify the initial response to TACE. The present study was to retrospectively compare(More)
  • 1